Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 66 entries
View as:

An Open Trial to Assess the Tolerability of AVANZ® Salsola Immunotherapy

Phase: N/A Priority: Normal
NCT ID: NCT02065856 Org: User:
Start: 12/31/13 End: 12/31/14 Due: 12/31/15

Efficacy and Safety Trial of SLITone(TM) Birch in Subjects With Hayfever

Phase: N/A Priority: Normal
NCT ID: NCT00310466 Org: User:
Start: 06/30/05 End: 01/31/07 Due: 01/31/08

Comparative Real World Effectiveness of SQ Sublingual Immunotherapy (SLIT)-Tablets vs. Controls in Allergic Rhinitis and Asthma

Phase: N/A Priority: Normal
NCT ID: NCT05476484 Org: User:
Start: 04/01/22 End: 06/30/24 Due: 06/30/25

Comparison of Different Up-dosing Schedules With Osiris Phleum Pratense

Phase: N/A Priority: Normal
NCT ID: NCT01425788 Org: User:
Start: 08/31/11 End: 02/29/12 Due: 02/28/13

A Study of SCH 697243 in Participants With Grass Pollen Allergy Symptoms, With or Without Asthma (P08067)

Phase: N/A Priority: Normal
NCT ID: NCT01385371 Org: User:
Start: 06/30/11 End: 08/31/12 Due: 08/31/13

Safety Study of Ragweed Allergy Immunotherapy Tablet in Subjects 50 Years of Age and Older (Study P06081)

Phase: N/A Priority: Normal
NCT ID: NCT00978029 Org: User:
Start: 11/30/09 End: 02/28/10 Due: 02/28/11

A Trial of the ALK Grass Tablet in Subjects With Hayfever

Phase: N/A Priority: Normal
NCT ID: NCT00227279 Org: User:
Start: 10/31/04 End: 09/30/09 Due: 09/30/10

Tolerability of Grazax in Patients With Hayfever in Real Life Settings

Phase: N/A Priority: Normal
NCT ID: NCT01433510 Org: User:
Start: 11/30/07 End: 12/31/10 Due: 12/31/11

Molecular and Cellular Mechanism in Rhinitis Allergic Patients Treated With GRAZAX®

Phase: N/A Priority: Normal
NCT ID: NCT02437786 Org: User:
Start: 09/30/09 End: 12/31/14 Due: 12/31/15

Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet (SCH 39641) in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05234)

Phase: N/A Priority: Normal
NCT ID: NCT00770315 Org: User:
Start: 09/30/09 End: 05/31/11 Due: 05/31/12

Tolerability of Grazax-R in Children

Phase: N/A Priority: Normal
NCT ID: NCT00298701 Org: User:
Start: 02/28/06 End: 04/30/06 Due: 04/30/07

A Phase III Trial Assessing the Pharmacodynamic Effect and the Tolerability of Grazax Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00773240 Org: User:
Start: 04/30/08 End: 02/28/09 Due: 02/28/10

Changes in the Immune Response and Skin Reactivity of Grass Pollen Allergic Patients Treated With ALK Grass Tablets

Phase: N/A Priority: Normal
NCT ID: NCT00413556 Org: User:
Start: 01/31/07 End: 12/31/07 Due: 12/31/08

Intraseasonal Short-time Up-dosing With Alutard SQ Grasses

Phase: N/A Priority: Normal
NCT ID: NCT00807547 Org: User:
Start: 04/30/08 End: 01/31/09 Due: 01/31/10

Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)

Phase: N/A Priority: Normal
NCT ID: NCT01678807 Org: User:
Start: 10/31/12 End: 05/31/13 Due: 05/31/14

A Study in Adults With Grass Pollen-induced Rhinoconjunctivitis

Phase: N/A Priority: Normal
NCT ID: NCT04881461 Org: User:
Start: 05/10/21 End: 09/26/23 Due: 09/26/24

A Dose-response Evaluation of the SQ Tree SLIT-tablet Using an Environmental Exposure Chamber

Phase: N/A Priority: Normal
NCT ID: NCT02481856 Org: User:
Start: 06/30/15 End: 04/30/16 Due: 04/30/17

An Open Trial to Assess the Tolerability of AVANZ Mite Mix Immunotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01568190 Org: User:
Start: 12/31/11 End: 07/31/12 Due: 07/31/13

Evaluation of the Efficacy and Safety of AVANZ® Phleum Pratense in Grass Pollen-induced Allergic Rhinitis During Controlled Exposure in an Environmental Challenge Chamber

Phase: N/A Priority: Normal
NCT ID: NCT02166268 Org: User:
Start: 06/30/14 End: 10/31/15 Due: 10/31/16

A Dose Response Evaluation of SLITone Ultra HDM Mix Immunotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01728298 Org: User:
Start: 11/30/12 End: 08/31/13 Due: 08/31/14

Efficacy and Safety Trial of Pangramin SLIT HDM-mix in Subjects With House Dust Mite Induced Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT01603056 Org: User:
Start: 10/31/09 End: 02/29/12 Due: 02/28/13

A Study of Ragweed (Ambrosia Artemisiifolia) Allergy Immunotherapy Tablet in Adults With Ragweed Allergies (P05751)

Phase: N/A Priority: Normal
NCT ID: NCT01469182 Org: User:
Start: 11/30/11 End: 04/30/12 Due: 04/30/13

Safety of ALK Ragweed Tablet

Phase: N/A Priority: Normal
NCT ID: NCT00330083 Org: User:
Start: 05/31/06 End: - Due: -

Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)

Phase: N/A Priority: Normal
NCT ID: NCT01700192 Org: User:
Start: 01/31/13 End: 04/30/15 Due: 04/30/16

A Trial Evaluating Tolerability of Grazax Treatment in Combination With Antihistamine

Phase: N/A Priority: Normal
NCT ID: NCT01740284 Org: User:
Start: 09/30/08 End: 01/31/09 Due: 01/31/10